Risky sexual behavior by young men with HIV who have sex with men

December 07, 2015

Young men who have sex with men and have detectable levels of the human immunodeficiency virus (HIV) were more likely to report condomless anal sex, including with a partner not infected with HIV, than virologically suppressed young men who have sex with men, according to an article published online by JAMA Pediatrics.

HIV disproportionately affects men who have sex with men (MSM). Young MSM (YMSM, ages 13 to 29) are particularly vulnerable to HIV infection and more than one-quarter of new infections in the U.S. occur in YMSM. The success of treatment as prevention in reducing the number of new HIV infections among YMSM relies on HIV testing, antiretroviral treatment, adherence and viral suppression among YMSM with HIV. Behavioral approaches to improve engagement in care and medication adherence may need to occur in concert with interventions to reduce risky sexual behaviors, including condomless anal intercourse (CAI).

Patrick A. Wilson, Ph.D., of the Columbia University Mailman School of Public Health, New York, and coauthors examined differences in demographic and psychosocial factors between virologically suppressed YMSM and those with detectable HIV. The authors also sought to identify psychosocial factors associated with CAI and serodiscordant (between partners of differing HIV status) CAI among YMSM with detectable HIV viral load.

The authors studied 991 YMSM with HIV (ages 15 to 26) at 20 adolescent HIV clinics in the U.S. from December 2009 through June 2012. Of the 991 participants, 688 (69.4 percent) had a detectable HIV viral load. Nearly half of the YMSM (46.2 percent) reported CAI in the past three months and 31.3 percent reported serodiscordant CAI, according to the results.

More than half (266 or 54.7 percent) of YMSM with detectable HIV reported CAI, while 91 (44.4 percent) of virologically suppressed YMSM reported that behavior. Likewise, 187 (34.9 percent) of YMSM with detectable HIV reported CAI with a partner who was HIV-negative, while 57 (25 percent) of the virologically suppressed YMSM reported serodiscordant CAI, the study reports.

Analyses suggest that among YMSM with detectable HIV, those who reported problematic substance use were more likely to report CAI or serodiscordant CAI. Black YMSM with detectable viral load were less likely to report CAI or serodiscordant CAI. YMSM with detectable HIV who disclosed their HIV status to sex partners were more likely to report CAI compared with nondisclosing YMSM. Transgender study participants were less likely to report CAI than cisgender participants. Lastly, YMSM with detectable viral load who were employed were less likely to report serodiscordant CAI than those who were unemployed.

The authors note causation cannot be inferred from their study. The study sample also includes only YMSM with HIV who were linked to care and that may limit generalizability of the findings.

"Combination HIV prevention and treatment interventions, which include behavioral, biomedical and structural strategies to increase viral suppression and reduce HIV transmission risk behaviors, that target HIV-infected YMSM are needed. To truly curb HIV incidence among YMSM, we cannot solely rely on one strategy to prevent and treat HIV," the study concludes.
-end-
(JAMA Pediatr. Published online December 7, 2015. doi:10.1001/jamapediatrics.2015.3333. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: The study includes funding/support disclosures. Please see article for additional information, including other authors, author contributions and affiliations, etc.

Media Advisory: To contact corresponding author Patrick A. Wilson, Ph.D., call Stephanie Berger at 212-305-4372 or email sb2247@columbia.edu.

The JAMA Network Journals

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.